[
  {
    "ts": "2025-11-11T13:00:00+00:00",
    "headline": "Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine",
    "summary": "Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar TherapeuticsLOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced it has been named as one of the “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine. “",
    "url": "https://finance.yahoo.com/news/turn-therapeutics-gx-03-technology-130000938.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "e278ef48-d162-3e77-a348-283cb9b57777",
      "content": {
        "id": "e278ef48-d162-3e77-a348-283cb9b57777",
        "contentType": "STORY",
        "title": "Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine",
        "description": "",
        "summary": "Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar TherapeuticsLOS ANGELES, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced it has been named as one of the “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine. “",
        "pubDate": "2025-11-11T13:00:00Z",
        "displayTime": "2025-11-11T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/5174144e426c29f941b226cbf53dd813",
          "originalWidth": 376,
          "originalHeight": 126,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SFyDI6.pP.2tNxaLV86zog--~B/aD0xMjY7dz0zNzY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5174144e426c29f941b226cbf53dd813.cf.webp",
              "width": 376,
              "height": 126,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2qq5dhaRIOLOknWzA4KLmg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/5174144e426c29f941b226cbf53dd813.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/turn-therapeutics-gx-03-technology-130000938.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/turn-therapeutics-gx-03-technology-130000938.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TTRX"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "SAN.PA"
            },
            {
              "symbol": "APGE"
            },
            {
              "symbol": "NKTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T10:30:00+00:00",
    "headline": "Obesity Drugs Are About to Go Mass-Market",
    "summary": "For most of Big Pharma, drug discounts have largely been about damage control.  After months of tariff threats and talk of tougher pricing rules that weighed on their shares, several chief executives have made their way to the White House to announce drug-pricing deals in exchange for regulatory relief.  For  Eli Lilly’s    David Ricks  and  Novo Nordisk’s    Mike Doustdar,  who paid their own visit to the White House last week, the calculus is different.",
    "url": "https://www.wsj.com/health/pharma/ozempic-glp1-weight-loss-mass-market-f70f8484?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b2aa9d81-f8af-30ce-a574-a07b350656b9",
      "content": {
        "id": "b2aa9d81-f8af-30ce-a574-a07b350656b9",
        "contentType": "STORY",
        "title": "Obesity Drugs Are About to Go Mass-Market",
        "description": "",
        "summary": "For most of Big Pharma, drug discounts have largely been about damage control.  After months of tariff threats and talk of tougher pricing rules that weighed on their shares, several chief executives have made their way to the White House to announce drug-pricing deals in exchange for regulatory relief.  For  Eli Lilly’s    David Ricks  and  Novo Nordisk’s    Mike Doustdar,  who paid their own visit to the White House last week, the calculus is different.",
        "pubDate": "2025-11-11T10:30:00Z",
        "displayTime": "2025-11-11T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b2aa9d81-f8af-30ce-a574-a07b350656b9/obesity-drugs-are-about-to-go.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r3EYtfWi7DUenDdrNOIVjQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T5qoowdQPCQB7Wmdu4lvWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/d9fbb83aa02eec1c9b51828685ea6e31.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/ozempic-glp1-weight-loss-mass-market-f70f8484?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NOVO-B.CO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T05:34:17+00:00",
    "headline": "The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call",
    "summary": "Amgen’s third quarter results were well received by the market, reflecting robust volume-driven growth across its diversified portfolio. Management credited rising demand for key medicines—including Repatha, EVENITY, TEZSPIRE, and its rare disease and biosimilar portfolios—as major contributors to the company’s 12% year-over-year revenue increase. CEO Robert Bradway highlighted, “Volume growth reflects the strength of our portfolio and the value our medicines provide to patients and prescribers.",
    "url": "https://finance.yahoo.com/news/top-5-analyst-questions-amgen-053417943.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "b283264f-aeef-384e-93e2-0d40f461290c",
      "content": {
        "id": "b283264f-aeef-384e-93e2-0d40f461290c",
        "contentType": "STORY",
        "title": "The Top 5 Analyst Questions From Amgen’s Q3 Earnings Call",
        "description": "",
        "summary": "Amgen’s third quarter results were well received by the market, reflecting robust volume-driven growth across its diversified portfolio. Management credited rising demand for key medicines—including Repatha, EVENITY, TEZSPIRE, and its rare disease and biosimilar portfolios—as major contributors to the company’s 12% year-over-year revenue increase. CEO Robert Bradway highlighted, “Volume growth reflects the strength of our portfolio and the value our medicines provide to patients and prescribers.",
        "pubDate": "2025-11-11T05:34:17Z",
        "displayTime": "2025-11-11T05:34:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "AMGN Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cVRDvNeMN6SVWgnyfhcabA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/khfuGqTIKrJ0BdS6OOusRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/85fc5540fd7647d2927a8cba48ff7e92.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-amgen-053417943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-5-analyst-questions-amgen-053417943.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T05:33:47+00:00",
    "headline": "5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call",
    "summary": "GoodRx’s third quarter results were met with a moderate positive market response, as the company’s revenue modestly exceeded Wall Street expectations despite being flat year-over-year. Management highlighted a mix of strategic wins, such as expanded partnerships with pharmaceutical manufacturers and new pharmacy integrations, as key drivers. CEO Wendy Barnes cited the launch of direct-to-consumer pricing programs with major brands like Novo Nordisk and Amgen, as well as the rollout of the RxSmar",
    "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-goodrx-053347062.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2f8e5838-9f87-3e11-ae07-d2ed14861759",
      "content": {
        "id": "2f8e5838-9f87-3e11-ae07-d2ed14861759",
        "contentType": "STORY",
        "title": "5 Revealing Analyst Questions From GoodRx’s Q3 Earnings Call",
        "description": "",
        "summary": "GoodRx’s third quarter results were met with a moderate positive market response, as the company’s revenue modestly exceeded Wall Street expectations despite being flat year-over-year. Management highlighted a mix of strategic wins, such as expanded partnerships with pharmaceutical manufacturers and new pharmacy integrations, as key drivers. CEO Wendy Barnes cited the launch of direct-to-consumer pricing programs with major brands like Novo Nordisk and Amgen, as well as the rollout of the RxSmar",
        "pubDate": "2025-11-11T05:33:47Z",
        "displayTime": "2025-11-11T05:33:47Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/f67032fda276f3b6a08f0bc7855ee745",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "GDRX Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.NXJK1LIASnMF8nN2_trrw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/f67032fda276f3b6a08f0bc7855ee745.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0IUALnAgXtuPYr5OwZNlYA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/f67032fda276f3b6a08f0bc7855ee745.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-goodrx-053347062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-goodrx-053347062.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GDRX"
            },
            {
              "symbol": "NOVO-B.CO"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "KR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T14:00:02+00:00",
    "headline": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-140002539.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3c1822e9-755c-3531-89c3-8e20c9cfeef1",
      "content": {
        "id": "3c1822e9-755c-3531-89c3-8e20c9cfeef1",
        "contentType": "STORY",
        "title": "Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
        "pubDate": "2025-11-11T14:00:02Z",
        "displayTime": "2025-11-11T14:00:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
          "originalWidth": 900,
          "originalHeight": 745,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J2T_cDhaoaaQj0soPS_nNw--~B/aD03NDU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 900,
              "height": 745,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sWMlcbg78JI.iCrZWAER9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-140002539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/amgen-inc-amgn-trending-stock-140002539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T18:12:00+00:00",
    "headline": "Executive Calls DEI Rollbacks 'Shortsighted' for Business",
    "summary": "Ellen Kullman, board director for Amgen, Carbon, and Goldman Sachs weighs in on the delicate balance between stakeholders and shareholders when creating company policies that impact employee engagement.",
    "url": "https://finance.yahoo.com/video/executive-calls-dei-rollbacks-shortsighted-181200084.html",
    "source": "WSJ",
    "provider": "yfinance",
    "raw": {
      "id": "0471b790-9c93-397c-bd1d-31c904ae38a7",
      "content": {
        "id": "0471b790-9c93-397c-bd1d-31c904ae38a7",
        "contentType": "VIDEO",
        "title": "Executive Calls DEI Rollbacks 'Shortsighted' for Business",
        "description": "Ellen Kullman, board director for Amgen, Carbon, and Goldman Sachs weighs in on the delicate balance between stakeholders and shareholders when creating company policies that impact employee engagement.",
        "summary": "Ellen Kullman, board director for Amgen, Carbon, and Goldman Sachs weighs in on the delicate balance between stakeholders and shareholders when creating company policies that impact employee engagement.",
        "pubDate": "2025-11-11T18:12:00Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wall_street_journal_733/d52e6505fe08aca84bb439b833aa11b6",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Zpz7ukR32wJgGpMnxlkJIw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wall_street_journal_733/d52e6505fe08aca84bb439b833aa11b6.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m6X0OsbMsmHhtxcVnm2yMw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wall_street_journal_733/d52e6505fe08aca84bb439b833aa11b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "WSJ",
          "url": "https://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/executive-calls-dei-rollbacks-shortsighted-181200084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/executive-calls-dei-rollbacks-shortsighted-181200084.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "GS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:03:14+00:00",
    "headline": "Stock Market Today: Dow Surges As Shutdown End Nears; Buffett Stock Gets Hot (Live Coverage)",
    "summary": "The Dow Jones index rose Tuesday after the passage of the shutdown bill. Nvidia partner CoreWeave plunged on earnings.",
    "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-shutdown-bill-nvidia-nvda-coreweave-crwv/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "c6cda4d8-8d0b-3b29-9c5b-ee73af839621",
      "content": {
        "id": "c6cda4d8-8d0b-3b29-9c5b-ee73af839621",
        "contentType": "STORY",
        "title": "Stock Market Today: Dow Surges As Shutdown End Nears; Buffett Stock Gets Hot (Live Coverage)",
        "description": "",
        "summary": "The Dow Jones index rose Tuesday after the passage of the shutdown bill. Nvidia partner CoreWeave plunged on earnings.",
        "pubDate": "2025-11-11T20:03:14Z",
        "displayTime": "2025-11-11T20:03:14Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/c6cda4d8-8d0b-3b29-9c5b-ee73af839621/stock-market-today-dow.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qfXbDWevT1kktaKi4nbEsg--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/n6CI2UWteKBwrKXd_3zPLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/8e3f0f90c622d76c522be98b9f3975ee.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/market-trend/stock-market-today/dow-jones-sp500-nasdaq-shutdown-bill-nvidia-nvda-coreweave-crwv/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "SE"
            },
            {
              "symbol": "LIF"
            },
            {
              "symbol": "LIFX"
            },
            {
              "symbol": "RKLB"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CSCO"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "NKE"
            },
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T19:34:38+00:00",
    "headline": "Jim Cramer on Amgen: “Company Announced Some Very Promising Heart Attack Prevention Results”",
    "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer offered insights on. Cramer discussed the stock’s rally and the company’s cholesterol drug phase 3 trial. He stated: “In the last few weeks, the long-dormant healthcare sectors finally started to show a little life. It’s so inexpensive, it’s crazy. Take Amgen, the big biotech company […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-amgen-company-announced-193438037.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dfd6c628-12ec-3dcb-abd9-71dfe9a2aa56",
      "content": {
        "id": "dfd6c628-12ec-3dcb-abd9-71dfe9a2aa56",
        "contentType": "STORY",
        "title": "Jim Cramer on Amgen: “Company Announced Some Very Promising Heart Attack Prevention Results”",
        "description": "",
        "summary": "Amgen Inc. (NASDAQ:AMGN) is one of the stocks Jim Cramer offered insights on. Cramer discussed the stock’s rally and the company’s cholesterol drug phase 3 trial. He stated: “In the last few weeks, the long-dormant healthcare sectors finally started to show a little life. It’s so inexpensive, it’s crazy. Take Amgen, the big biotech company […]",
        "pubDate": "2025-11-11T19:34:38Z",
        "displayTime": "2025-11-11T19:34:38Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4ad266f25a10eaea977c48dcdb63500d",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EXBMdjzM15ZYMZZQFA3u2Q--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4ad266f25a10eaea977c48dcdb63500d.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sK6ffMWjabRWUakXEpyL2g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4ad266f25a10eaea977c48dcdb63500d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-company-announced-193438037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-amgen-company-announced-193438037.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:56:03+00:00",
    "headline": "Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia",
    "url": "https://finance.yahoo.com/news/lantheus-enovis-evolent-health-repligen-205603236.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "8ddd9f40-02a7-3e49-85c0-e007181a3b2f",
      "content": {
        "id": "8ddd9f40-02a7-3e49-85c0-e007181a3b2f",
        "contentType": "STORY",
        "title": "Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia",
        "pubDate": "2025-11-11T20:56:03Z",
        "displayTime": "2025-11-11T20:56:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/bb7f9d5bba1203b3a11de602325eefa9",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LNTH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bFBOKdx9VfiWt7NOpKEwJw--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/bb7f9d5bba1203b3a11de602325eefa9.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Nyc3_g1KfkIkfT9DxlGGRA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/bb7f9d5bba1203b3a11de602325eefa9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/lantheus-enovis-evolent-health-repligen-205603236.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lantheus-enovis-evolent-health-repligen-205603236.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "RGEN"
            },
            {
              "symbol": "CORT"
            },
            {
              "symbol": "LNTH"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ENOV"
            },
            {
              "symbol": "EVH"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:59+00:00",
    "headline": "Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia",
    "url": "https://finance.yahoo.com/news/merck-elanco-myriad-genetics-neogen-205559213.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "7b4cf72c-84d7-36bd-99db-965917729334",
      "content": {
        "id": "7b4cf72c-84d7-36bd-99db-965917729334",
        "contentType": "STORY",
        "title": "Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied. This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia",
        "pubDate": "2025-11-11T20:55:59Z",
        "displayTime": "2025-11-11T20:55:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/ebe2be3c9f70cfc1092fc0a56a0c75dc",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "MRK Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PqkkAVnP2lidjvyb58UUUQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/ebe2be3c9f70cfc1092fc0a56a0c75dc.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jUpD9l9St2LHULbO70D5fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/ebe2be3c9f70cfc1092fc0a56a0c75dc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-elanco-myriad-genetics-neogen-205559213.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-elanco-myriad-genetics-neogen-205559213.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "ELAN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MYGN"
            },
            {
              "symbol": "NEOG"
            },
            {
              "symbol": "CI"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:52+00:00",
    "headline": "Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
    "url": "https://finance.yahoo.com/news/viatris-oscar-health-biomarin-pharmaceutical-205552442.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "618ffb77-459d-374d-a0be-7ef5bc8475f8",
      "content": {
        "id": "618ffb77-459d-374d-a0be-7ef5bc8475f8",
        "contentType": "STORY",
        "title": "Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
        "pubDate": "2025-11-11T20:55:52Z",
        "displayTime": "2025-11-11T20:55:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "VTRS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZ5PSZg5aKFn_8IHve8fGQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4bPZw8EZ18ugKQPfipbnLw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/ad9a5e2f85d880e3e7b521395022f4d3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viatris-oscar-health-biomarin-pharmaceutical-205552442.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viatris-oscar-health-biomarin-pharmaceutical-205552442.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "OSCR"
            },
            {
              "symbol": "BMRN"
            },
            {
              "symbol": "QDEL"
            },
            {
              "symbol": "BLCO"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:50+00:00",
    "headline": "Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
    "url": "https://finance.yahoo.com/news/elevance-health-labcorp-privia-health-205550838.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2a5d37e9-5b24-3e70-922c-fb8a171be271",
      "content": {
        "id": "2a5d37e9-5b24-3e70-922c-fb8a171be271",
        "contentType": "STORY",
        "title": "Elevance Health, Labcorp, Privia Health, Fortrea, and Amgen Shares Are Soaring, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
        "pubDate": "2025-11-11T20:55:50Z",
        "displayTime": "2025-11-11T20:55:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/9118b9470a765e3f78db99113eb78ae1",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "ELV Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Cr2lLNZEXq19Rf31LEUNYg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/9118b9470a765e3f78db99113eb78ae1.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FQBXD5u2rnonHNKNIKcVQg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/9118b9470a765e3f78db99113eb78ae1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-labcorp-privia-health-205550838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/elevance-health-labcorp-privia-health-205550838.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "PRVA"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "ELV"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LH"
            },
            {
              "symbol": "FTRE"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:41+00:00",
    "headline": "Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
    "url": "https://finance.yahoo.com/news/bio-techne-tandem-diabetes-align-205541331.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "2a0389a7-4e9b-39ef-913c-c5c69feb0a61",
      "content": {
        "id": "2a0389a7-4e9b-39ef-913c-c5c69feb0a61",
        "contentType": "STORY",
        "title": "Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
        "pubDate": "2025-11-11T20:55:41Z",
        "displayTime": "2025-11-11T20:55:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "TECH Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LYiy8pdxjjKKPO37OJyQAg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/D4gEv3cExkoBPyh482djbA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/4439f8d76fe0b091f617ad2a71c09aaf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tandem-diabetes-align-205541331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bio-techne-tandem-diabetes-align-205541331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "TECH"
            },
            {
              "symbol": "TNDM"
            },
            {
              "symbol": "TFX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ALGN"
            },
            {
              "symbol": "DXCM"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:41+00:00",
    "headline": "Inspire Medical Systems, UFP Technologies, Astrana Health, Option Care Health, and The Pennant Group Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
    "url": "https://finance.yahoo.com/news/inspire-medical-systems-ufp-technologies-205541793.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "467ec8ab-5e0c-3a9f-83a1-23d6c6371dfe",
      "content": {
        "id": "467ec8ab-5e0c-3a9f-83a1-23d6c6371dfe",
        "contentType": "STORY",
        "title": "Inspire Medical Systems, UFP Technologies, Astrana Health, Option Care Health, and The Pennant Group Shares Skyrocket, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
        "pubDate": "2025-11-11T20:55:41Z",
        "displayTime": "2025-11-11T20:55:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/e6819ff7fc05bf31de9f3d9fd810de90",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "INSP Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fFq8IDRiCK2jTH7StBxVvA--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/e6819ff7fc05bf31de9f3d9fd810de90.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LTXxruVxxu6sHJ6YXz3BGQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/e6819ff7fc05bf31de9f3d9fd810de90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/inspire-medical-systems-ufp-technologies-205541793.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/inspire-medical-systems-ufp-technologies-205541793.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "PNTG"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "INSP"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "UFPT"
            },
            {
              "symbol": "ASTH"
            },
            {
              "symbol": "OPCH"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T20:55:41+00:00",
    "headline": "Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
    "url": "https://finance.yahoo.com/news/pfizer-amneal-jazz-pharmaceuticals-bd-205541327.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "87710d90-3fc3-3bc0-97b0-84080c6d4487",
      "content": {
        "id": "87710d90-3fc3-3bc0-97b0-84080c6d4487",
        "contentType": "STORY",
        "title": "Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know",
        "description": "",
        "summary": "A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns.",
        "pubDate": "2025-11-11T20:55:41Z",
        "displayTime": "2025-11-11T20:55:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "PFE Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o3tZoPUio75qXATbHoc_Hg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o5rZqD7vIoFGnsFYAS_Ztw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/1ff5bd386bd84b91b34108fd5f310eca.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-amneal-jazz-pharmaceuticals-bd-205541327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-amneal-jazz-pharmaceuticals-bd-205541327.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "9984.T"
            },
            {
              "symbol": "BDX"
            },
            {
              "symbol": "AMRX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "JAZZ"
            },
            {
              "symbol": "DVA"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "MU"
            },
            {
              "symbol": "ORCL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-11T21:45:00+00:00",
    "headline": "Government Shutdown Nears End, Lifting Investors’ Spirits—and Stocks",
    "summary": "U.S. stocks climbed Tuesday after Congress moved closer to ending the government shutdown, promising investors less commercial disruption and better insight into the state of the economy.  A day after tech shares powered indexes higher, investors shifted money to other parts of the market, leading to sizable gains in the healthcare, energy and materials sectors.  “It makes sense just to have some digestion of a really strong day yesterday,” said  Matt Stucky,  chief portfolio manager of equities at Northwestern Mutual Wealth Management.",
    "url": "https://www.wsj.com/finance/stocks/government-shutdown-nears-end-lifting-investors-spiritsand-stocks-f0f6ac07?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "14fc7070-da9a-3b58-94d4-ceea675337da",
      "content": {
        "id": "14fc7070-da9a-3b58-94d4-ceea675337da",
        "contentType": "STORY",
        "title": "Government Shutdown Nears End, Lifting Investors’ Spirits—and Stocks",
        "description": "",
        "summary": "U.S. stocks climbed Tuesday after Congress moved closer to ending the government shutdown, promising investors less commercial disruption and better insight into the state of the economy.  A day after tech shares powered indexes higher, investors shifted money to other parts of the market, leading to sizable gains in the healthcare, energy and materials sectors.  “It makes sense just to have some digestion of a really strong day yesterday,” said  Matt Stucky,  chief portfolio manager of equities at Northwestern Mutual Wealth Management.",
        "pubDate": "2025-11-11T21:45:00Z",
        "displayTime": "2025-11-11T21:45:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/14fc7070-da9a-3b58-94d4-ceea675337da/government-shutdown-nears.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/1d7eaa89f8a4a83c32275a7e29ac5aa5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jkAvOgOzsLBLPc0ImW57Sw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/1d7eaa89f8a4a83c32275a7e29ac5aa5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/NqHzCsosxtp1Td3GWqt3_g--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/1d7eaa89f8a4a83c32275a7e29ac5aa5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/finance/stocks/government-shutdown-nears-end-lifting-investors-spiritsand-stocks-f0f6ac07?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMGN"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "CRWV"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]